Clinical trial reportJournal of medicinal chemistryPublished
Discovery of MK-1088 as a Potent A2A/A2B Adenosine Receptor Dual-Antagonist for Cancer Immunotherapy
12 of 44 authors shown in byline order.
Regional connection
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
- Institution
- Merck & Co.
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Journal of medicinal chemistry
- Published
- Topic
- Disease research
- Subject terms
- CHO Cells; Animals; Dogs; Macaca mulatta; Humans; Cricetulus; Mice; Rats; Rats, Wistar; Neoplasms; Triazoles; Quinazolines
- PubMed ID
- 42084562
- Added to directory
- Source checked